We have harnessed our patient-specific, induced pluripotent stem cell–derived, multicell lung organoid model to investigate critical aspects of COVID-19, including viral tropism and routes of entry, lung-specific immune response, and a role for surfactant protein B in innate immunity, viral surveillance, cell survival, and inflammation. Here, SFTPB is linked to COVID-19.